FDA-Drug2026-09-02Class IIMISBRANDING
Accord Healthcare levothyroxine sodium tablets recalled for subpotent drug
What this means
Accord Healthcare is recalling certain batches of levothyroxine sodium 88 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients who depend on it to manage thyroid conditions.
- Check your prescription bottle for lot numbers D2401813, D2401814, D2500200, or D2500219 with expiration dates of 08/31/2026 or 12/31/2026.
- Contact your pharmacy or doctor if you have one of these lots — do not stop taking your medication without guidance.
- Your doctor may want to check your thyroid levels or switch you to another levothyroxine supply.
The agency's original wording
Hazard
Subpotent Drug
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Products
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-17.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0778-2026More Accord Healthcare recalls
- FDA-Drug2026-09-02Accord Healthcare levothyroxine sodium tablets recalled for subpotent drug
- FDA-Drug2026-09-02Accord Healthcare levothyroxine 100 mcg tablets recalled for subpotency
- FDA-Drug2026-09-02Accord Healthcare levothyroxine sodium 150 mcg tablets recalled for subpotent drug
- FDA-Drug2026-09-02Accord Healthcare Levothyroxine Sodium 175 mcg tablets recalled for subpotency
- FDA-Drug2026-09-02Accord Healthcare Levothyroxine Sodium 300 mcg tablets recalled for subpotency
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.